share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Storch Gerald L

施貴寶 | 4:持股變動聲明-董事 Storch Gerald L

SEC announcement ·  04/03 06:46
牛牛AI助理已提取核心訊息
Gerald L Storch, associated with Bristol-Myers Squibb (BMY), has been involved in a transaction dated 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed. The report does not specify Storch's relationship to the issuer, nor does it provide information on the number of shares held after the action.
Gerald L Storch, associated with Bristol-Myers Squibb (BMY), has been involved in a transaction dated 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed. The report does not specify Storch's relationship to the issuer, nor does it provide information on the number of shares held after the action.
與百時美施貴寶(BMY)有聯繫的傑拉爾德·斯托奇參與了2024年3月31日的交易。該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值,尚未披露。該報告沒有具體說明斯托奇與發行人的關係,也沒有提供有關行動後持有的股票數量的信息。
與百時美施貴寶(BMY)有聯繫的傑拉爾德·斯托奇參與了2024年3月31日的交易。該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值,尚未披露。該報告沒有具體說明斯托奇與發行人的關係,也沒有提供有關行動後持有的股票數量的信息。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。